alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### In the Matter of Jacqueline Fleming, Appellant, v KidsPeace National Centers et al., Respondents.

[942 NYS2d 393]

Appeal from a judgment of the Supreme Court, Erie County (Patrick H. NeMoyer, J.), entered May 26, 2010 in a proceeding pursuant to CPLR article 78. The judgment dismissed the petition.

It is hereby ordered that the judgment so appealed from is unanimously affirmed without costs.

Memorandum: Petitioner commenced this CPLR article 78 proceeding seeking to annul the determination to “terminate]” her certification as a foster parent. Petitioner contends that she was denied procedural due process because she was not given notice and opportunity to be heard with respect to the termination. We reject that contention. KidsPeace National Centers (respondent) notified petitioner by letter that it would “close” her certification effective July 10, 2009. Petitioner’s current certification to board children expired July 2, 2009 in any event, and thus respondent essentially notified petitioner that it would not renew her certification. “A hearing is required only where a license is to be suspended or revoked and . . . due process does not mandate such a hearing before the denial of a renewal *1413license” *(Matter of M.S.B.A. Corp. v Markowitz,*23 AD3d 390, 391 [2005]; *see Matter of Daxor Corp. v State of N.Y. Dept. of Health,*90 NY2d 89, 98 [1997], *rearg denied*90 NY2d 937 [1997], *cert denied*523 US 1074 [1998]; *Testwell, Inc. v New York City Dept. of Bldgs.,*80 AD3d 266, 273-274 [2010]). Thus, the only rights petitioner had to notice and an opportunity to be heard were pursuant to respondent’s own policies and the applicable state regulation, and “[t]he record amply demonstrates that these requirements were satisfied” *(Testwell, Inc.,*80 AD3d at 274). With respect to the state regulation, petitioner was given timely notice of respondent’s decision and the reasons therefor, as required by 18 NYCRR 443.11 (a), and was afforded the requisite opportunity “to meet with an official of the agency to review the decision and the reasons for the agency decision” (18 NYCRR 443.11 [b]). We have reviewed petitioner’s remaining contentions and conclude that they are without merit. Present — Scudder, EJ., Smith, Centra, Fahey and Peradotto, JJ.
IN THE COMMONWEALTH COURT OF PENNSYLVANIA

David George Lusick, :

Appellant :

:

v. : No. 1952 C.D. 2015

:

Lynne Abraham, Elizabeth :

Varki Jobes, John Hunter Bennett, :

Thomas Dolgenos, Robert M. Falin, :

Ronald Eisenberg, Arnold Gordon, :

Lynne Herbert O'Connor, :

Karen Brancheau, Hugh J. Burns, :

Brad Bender, Andrew Klein :

O R D E R

NOW, September 7, 2017

, having considered appellant’s application

for reargument

/reconsideration , the application is denied.

MARY HANNAH LEAVITT,

P resident Judge
**EXHIBIT32.2**

**CertificationPursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of1934 and U.S.C. Section 1350**

I, Alan Fuhrman, SeniorVice President and Chief Financial Officer of Sonus Pharmaceuticals, Inc. (the “Company”),certify, pursuant to Rule 13a-14(b) orRule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350,that:

(1)                                  theQuarterly Report on Form 10-Q of the Company for the quarterly period endedJune 30, 2007 (the “Report”) fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.78m or 78o(d)); and

(2)                                  theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.
| Dated: | August 3, 2007 |                            |   |
|--------|----------------|---------------------------------|--------|
|   |           | /s/ Alan Fuhrman                |   |
|   |           | Alan Fuhrman                    |
|   |           | Senior Vice President and Chief |
|   |           | Financial Officer               |

 

----
**EXHIBIT 23.1**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTINGFIRM**

 

Weconsent to the incorporation by reference in Registration Statement Nos.33-35941, 33-43868, 33-43866, 33-45994, 33-45142, 33-54382, 33-65125, 33-69946,33-75088, 333-28593 and 333-80729 on Form S-3 and the RegistrationStatement Nos. 33-85154, 333-72916, 333-72918, 333-72920, 333-113387, 333-113388and 333-126651 on Form S-8 of our reports dated March 16, 2006, relatingto the consolidated financial statements of Bentley Pharmaceuticals, Inc.and subsidiaries and management’s report on the effectiveness of internalcontrol over financial reporting, appearing in this Annual Report on Form 10-Kof Bentley Pharmaceuticals, Inc. and subsidiaries for the year ended December 31,2005.

 
| /s/ Deloitte & Touche LLP |   |
|------------------------------------|--------|
|                               |
| Boston, Massachusetts              |
| March 16, 2006                     |

 

----
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 318 Agreed to Senate (ATS)]

112th CONGRESS
  1st Session
S. RES. 318

To authorize the printing of a revised edition of the Senate Rules and 
                                Manual.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 9, 2011

 Mr. Schumer submitted the following resolution; which was considered 
                             and agreed to

_______________________________________________________________________

                               RESOLUTION

 
To authorize the printing of a revised edition of the Senate Rules and 
                                Manual.

    Resolved, That--
            (1) the Committee on Rules and Administration shall prepare 
        a revised edition of the Senate Rules and Manual for the use of 
        the 112th Congress;
            (2) the manual shall be printed as a Senate document; and
            (3) in addition to the usual number of copies, 1,500 copies 
        of the manual shall be bound, of which--
                    (A) 500 paperbound copies shall be for the use of 
                the Senate; and
                    (B) 1,000 copies shall be bound (550 paperbound; 
                250 nontabbed black skiver; 200 tabbed black skiver) 
                and delivered as may be directed by the Committee on 
                Rules and Administration.
                                 <all>
```
CONSENT OF INDEPENDENT AUDITORS


We  hereby  consent  to the  incorporation  by  reference  in  the  Registration
Statements of  Bio-Imaging  Technologies,  Inc. (i) on Form S-8 (relating to the
Company's  1991 Stock  Option  Plan) filed on March 17, 1995  (Registration  No.
33-90412),  (ii) on Form S-8 (relating to the Company's  1991 Stock Option Plan)
filed  on  January  17,  1994  (Registration  No.  33-74152),  (iii) on Form S-8
(relating  to the  Company's  1991  Stock  Option  Plan)  filed on March 3, 1997
(Registration No. 33-22661),  (iv) on Form S-3 declared  effective March 8, 1994
(Registration  No. 33-75370),  and (v) on Form S-3 declared  effective April 18,
1997  (Registration  No.  33-25477) of our report  dated  October 9, 1997 on our
audits of the  consolidated  financial  statements of Bio-Imaging  Technologies,
Inc. and  Subsidiaries  as of September 30, 1997 and 1996 and for the years then
ended, which reports are included in this Annual Report on Form 10-KSB.




GOLDSTEIN GOLUB KESSLER & COMPANY, P.C.
New York, New York

December 16, 1997
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Houston, Texas
 close




            Search small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area Houston, Texas People & Locations







Robert  Shulman

                                                                (MD)
                        Houston, Texas

                        




                        
                        Nutrition Scientist
                        Phone: (713) 798-7145
                        
                        
                        Fax: (713) 798-7187(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
<PAGE>   1

EXHIBIT 23.1  CONSENT OF PRICE WATERHOUSE LLP

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Prospectus
constituting part of the Registration Statement on Form S-3 (No. 33-98100),
the Prospectus constituting part of the Registration Statement on Form S-8 (No.
333-09841) and the Prospectus constituting part of Post-Effective Amendment No.
1 on Form S-3 to Form SB-2 (No. 33-78940) of Innovative Tech Systems, Inc. of
our report dated May 7, 1997 appearing on page F-2 of this Form 10-K.


PRICE WATERHOUSE LLP


Philadelphia, Pennsylvania

May 14, 1997
EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-QSB of OmniComm Systems, Inc. (the Company) for the quarter
ended March 31, 2007, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, being, Cornelis F. Wit, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | 1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------

/s/ Cornelis F. Wit

Cornelis F. Wit

President, Chief Executive Officer and Director

May 15, 2007
##### 



CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002


(18 U.S.C. SECTION 1350)


In connection with the Annual Report of CHS Inc.
(the Company) on Form 10-K for the fiscal year
ended August 31, 2003 as filed with the Securities and
Exchange Commission on the date hereof (the Report),
I, John Schmitz, Executive Vice President and Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:



| |                                                                                                                                                                
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) The Report fully complies with the
    requirements of section 13(a) or 15(d) of the Securities
    Exchange Act of 1934; and                              
|
| | (2) The information contained in the Report
    fairly presents, in all material respects, the financial
    condition and result of operations of the Company.



| |                                                         
| | --------------------------------------------------------
| | /s/ JOHN SCHMITZ                                        
| |                                                         
| | John Schmitz                                            
| | Executive Vice President and Chief Financial
    Officer

November 21, 2003
EXHIBIT 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,



AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report on Form 10-KSB of Bio-Imaging Technologies, Inc. (the Company) for the year ended December 31, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Mark L. Weinstein, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:



(1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.



|                      |  |                                                                                       
|--------------------- |  | --------------------------------------------------------------------------------------
|Dated: March 31, 2005 |  | /s/    MARK L.
WEINSTEIN*                                                             
|                      |  | Mark L. Weinstein, President and Chief Executive Officer (Principal Executive Officer)

---

|* | A signed original of this written statement required by section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
|- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Opinion issued January 7, 2020

In The 

## Court of Appeals For The 

## First District of Texas

———————————— NO. 01
- 1 9
- 00 976
- C R NO. 01
- 19
- 00977
- C R NO. 01
- 19
- 00978
- C R

——————————— IN RE DAVID RODRIGUE Z , Relator

Original Proceeding on Petition for Writ of Mandamus

MEMORANDUM OPINION
Relator , David Rodriguez, has filed a pro se petition for writ of mandamus seeking to compel the trial court to rule on all motions filed in three cases. 1

1 The underlying cases are State of Texas v. David Rodriguez , Cause Numbers 1595712, 1595713, 1600804, pending in the 174th District Court of Harris County, Texas, the Honorable Hazel B. Jones presiding.2

We deny the petition for writ of mandamus. 2 We dismiss any pending motions

as moot. PER CURIAM
Panel consists of Justices Keyes , Goodman , and Countiss. Do not publish. T EX

. R. A PP

. P. 47.2(b).

2 Relator’s petition for writ of mandamus does not comply with Rule 52.3. See T EX

. R. A PP

. P. 52.3(a)

– (k).
INDEPENDENT AUDITORS' CONSENT



We consent to the  incorporation  by reference in Registration  Statements (Nos.
33-35941,   33-43868,  33-43866,  33-45994,  33-45142,  33-54382,  33-69946  and
33-75088) of Bentley  Pharamceuticals,  Inc. and subsidiaries (the "Company") on
Form S-3 and the Registration  Statement No. 33-85154 of the Company on Form S-8
of our reports dated March 27, 1997, appearing in the Annual Report on Form 10-K
of the Company for the year ended December 31, 1996.






/s/ Deloitte & Touche LLP

DELOITTE & TOUCHE LLP
Tampa, Florida
March 27, 1997
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAY-31-1997
<PERIOD-END>                               MAY-31-1997
<CASH>                                      38,064,191
<SECURITIES>                                         0
<RECEIVABLES>                              213,501,012
<ALLOWANCES>                                10,975,000
<INVENTORY>                                248,373,247
<CURRENT-ASSETS>                           579,517,494
<PP&E>                                     430,450,368
<DEPRECIATION>                             206,299,403
<TOTAL-ASSETS>                             976,705,753
<CURRENT-LIABILITIES>                      467,706,447
<BONDS>                                    232,458,466
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                 385,099,313
<TOTAL-LIABILITY-AND-EQUITY>               976,705,753
<SALES>                                  7,024,839,260
<TOTAL-REVENUES>                         7,109,413,861
<CGS>                                    6,967,937,476
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            63,341,552
<LOSS-PROVISION>                             2,859,263
<INTEREST-EXPENSE>                          19,378,833
<INCOME-PRETAX>                             58,756,000
<INCOME-TAX>                                 6,200,000
<INCOME-CONTINUING>                         52,556,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                52,556,000
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
<PAGE>   1

                                   EXHIBIT 23

                  CONSENT OF THE INDEPENDENT PUBLIC ACCOUNTANTS

           We hereby consent to the incorporation by reference in the
Registration Statements of HEARx Ltd. on Form S-8 (filed September 13, 1994),
Form S-8 (filed July 19, 1996), Form S-3 (File No. 333-4303), Form S-3 (File No.
333-4639), Form S-3 (File No. 333-11429) , Form S-3 (File No. 333-18753), Form
S-3 (File No. 333-24357) and Form S-3 (File No. 333-25169) of our report dated
March 13, 1998, relating to the consolidated financial statements and financial
statement schedule of the Registrant and its subsidiaries for the year ended
December 26, 1997, included in the Registrant's Annual Report on Form 10-K for
fiscal year ended December 26, 1997.

West Palm Beach, Florida                                       BDO Seidman, LLP
March 13, 1998



                                       49
<TABLE> <S> <C>

<ARTICLE>           5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated statements of financial condition and the consolidated
statements of operation of Unified Financial Services, Inc., previously
filed by the Company with the Commission, and is qualified in its
entirety by reference to such filing.
</LEGEND>
<RESTATED>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                         542,981
<SECURITIES>                                   375,763
<RECEIVABLES>                                  975,413
<ALLOWANCES>                                     2,041
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,016,469
<PP&E>                                       1,474,449
<DEPRECIATION>                                 938,650
<TOTAL-ASSETS>                               3,795,117
<CURRENT-LIABILITIES>                          994,207
<BONDS>                                              0
<COMMON>                                         9,050
<PREFERRED-MANDATORY>                           17,069
<PREFERRED>                                          0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 3,795,117
<SALES>                                              0
<TOTAL-REVENUES>                             1,572,315
<CGS>                                                0
<TOTAL-COSTS>                                  469,072
<OTHER-EXPENSES>                             1,172,789
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,317
<INCOME-PRETAX>                                (70,883)
<INCOME-TAX>                                     4,275
<INCOME-CONTINUING>                            (75,138)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (75,138)
<EPS-PRIMARY>                                    (0.24)
<EPS-DILUTED>                                    (0.11)
        

</TABLE>
# C_2005256EN.01001701.xml

| 15.10.2005 | EN | Official Journal of the European Union | C 256/17 |
| --- | --- | --- | --- |

15.10.2005

EN

Official Journal of the European Union

C 256/17

---

Publication of decisions by Member States to grant or revoke operating licenses pursuant to Article 13(4) of Council Regulation (EEC) No 2407/92 on licensing of air carriers (1)
   (2)

1

2

(2005/C 256/10)

(Text with EEA relevance)

LITHUANIA

Operating licences granted

Category B:   Operating licences including the restriction of Article 5(7)(a) of Regulation (EEC) No 2407/92

| Name of air carrier | Address of air carrier | Permitted to carry | Decision effective since |
| --- | --- | --- | --- |
| JSC Aviation Training Center | Asiukliu str. 11/18, Vilnius, Lithuania | passengers, mail, cargo | 15.1.2005 |

Name of air carrier

Address of air carrier

Permitted to carry

Decision effective since

JSC Aviation Training Center

Asiukliu str. 11/18, Vilnius, Lithuania

passengers, mail, cargo

15.1.2005

---

(1)  OJ L 240, 24.8.1992, p. 1.

1

(2)  Communicated to the European Commission before 31.8.2005.

2

---